Financials

  • Market Capitalization 19.37 M
  • Employee 14
  • Founded 1997
  • CEO N/A
  • Website www.lipocine.com
  • Headquarter Delaware, United States
  • FIGI BBG0029L1X69
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-4.75
Price to sales ratio
23.19

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4620
KALA
KALA BIO, Inc. - Common Stock
1.09 USD-7.63%-27.81%-59.33%-81.21%20.26 M USD
4629
LGVN
Longeveron Inc. - Class A Common stock
0.63 USD-7.35%-3.08%-23.17%+10.27%19.62 M USD
4637
NCEL
NewcelX Ltd. - Ordinary Shares
4.00 USD-4.76%0.00%+21.21%-21.26%19.19 M USD
4638
ICU
SeaStar Medical Holding Corporation - Common Stock
4.79 USD-3.23%-0.62%+54.52%+94.72%19.15 M USD

Frequently asked questions about Lipocine Inc. - Common Stock

What is the Lipocine Inc. - Common Stock stock price today?

The current price of Lipocine Inc. - Common Stock (LPCN) is 2.35. Over the past 24 hours, the stock has changed by -2.49%. Follow the LPCN chart for real-time price dynamics.

What is the stock ticker of Lipocine Inc. - Common Stock?

Lipocine Inc. - Common Stock trades under the ticker LPCN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Lipocine Inc. - Common Stock stock going up?

LPCN has changed by -2.89% over the last week, +3.98% over the last month, and -18.97% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Lipocine Inc. - Common Stock net income for the last quarter?

Lipocine Inc. - Common Stock reported net income of -3.67 M for the last quarter. The previous quarter showed -2.37 M, which means net income changed by -54.93%.

How many employees does Lipocine Inc. - Common Stock have?

As of the latest available data, Lipocine Inc. - Common Stock has 14 employees. Workforce size can provide additional context about the company's scale and operations.

What is Lipocine Inc. - Common Stock EBITDA?

Lipocine Inc. - Common Stock EBITDA is -3.95 M, and its EBITDA margin is -3 304.84%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Lipocine Inc. - Common Stock stock?

You can buy Lipocine Inc. - Common Stock (LPCN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Lipocine Inc. - Common Stock stock?

Investing in Lipocine Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the LPCN chart and related analysis on metatrader.com as part of your research.

News